Professor Stip and colleagues state that treatment with fast-dissolution (FD) olanzapine could be associated with a lower risk of weight gain when compared with treatment with the conventional formulation of olanzapine. This suggestion is very intriguing; nonetheless, this letter raises some issues. …
Anzeige
Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten